Unsealed FCA Suit Accuses Pfizer Of Off-Label Marketing
A federal court on Tuesday unsealed two ex-Pfizer Inc. employees' qui tam suit alleging the drugmaker marketed anti-fungal medication Vfend for off-label use that put patients at risk and caused the...To view the full article, register now.
Already a subscriber? Click here to view full article